4
Changes in Ownership
Cardiff Oncology, Inc. Filed Acc 0001104659-17-055891
Chief Scientific Officer gave up 12,928 shares (to pay taxes)
- Chief Scientific Officer acquired 30,001 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Erlander Mark Chief Scientific Officer | 2017-09-02 | Option exercise | +30,001 | 61,033 | D: show line 1 in the form | ||
| Erlander Mark Chief Scientific Officer | 2017-09-02 | Shares withheld for taxes | −12,928 | 48,051 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Erlander Mark Chief Scientific Officer | 2017-09-02 | Option exercise · Restricted Stock Units | −30,001 | 165,000 | D: show line 3 in the form |
Loading xslF345X03/a4.xml…